Giving very late thrombolysis to patients with large-vessel occlusion small core strokes did not show a significant benefit in the TIMELESS trial, although there were some encouraging findings.
Patients presenting with ischemic stroke found to have atrial fibrillation can safely start a direct oral anticoagulant much earlier than starting occurs in current practice, a new study suggests.
The largest trial so far conducted with the new bolus thrombolytic, tenecteplase, in acute ischemic stroke has shown noninferiority to alteplase with similar safety.